Black Rose Industries Limited , a prominent player in the chemicals sector, has announced its financial results for the second quarter and half-year ended September 30, 2025, along with a significant board appointment.

Financial Performance

The company reported a consolidated revenue from operations of ₹8,397.60 crore for Q2 FY2026, compared to ₹9,304.62 crore in the same quarter of the previous fiscal year. For the half-year ended September 30, 2025, the consolidated revenue stood at ₹14,382.55 crore.

The company's net profit for Q2 FY2026 was ₹442.63 crore, compared to ₹470.92 crore in Q2 FY2025. For the half-year, the net profit reached ₹861.53 crore.

New Independent Director Appointment

In a move to strengthen its corporate governance, Black Rose Industries has appointed Mr. Mayur Desai as an Additional Director (Non-Executive Independent) for a five-year term, effective November 11, 2025. This appointment is subject to member approval through a postal ballot.

Mr. Desai brings over four decades of experience as a Chartered Accountant, with expertise in:

• Taxation
• Transaction advisory
• Corporate governance
• Financial management

His extensive background includes advising listed companies, multinational corporations, and start-ups on complex tax and regulatory matters. Mr. Desai has also led several mergers and acquisitions transactions.

Subsidiary Operations

The company disclosed that its wholly-owned subsidiary, B.R. Chemicals Co. Ltd. in Japan, has been classified as a discontinued operation. This follows the Board's decision on August 14, 2025, to initiate steps for the closure, sale, or transfer of 100% shareholding in the subsidiary.

For the half-year ended September 30, 2025, the discontinued operations reported:

• Total income: ₹1.37 lakh
• Expenses: ₹7.07 lakh
• Loss: ₹5.70 lakh
• Comprehensive income: ₹2.08 lakh
• Assets: ₹33.68 lakh

Looking Ahead

While the company faces challenges, including the discontinuation of its Japanese subsidiary operations, the appointment of Mr. Mayur Desai as an independent director signals Black Rose Industries' commitment to robust corporate governance and strategic growth.

Black Rose Industries Limited , a prominent player in the chemicals sector, has announced its financial results for the first quarter ended June 30, 2025, along with several significant corporate decisions. The company's Board of Directors approved these measures during a meeting held on August 14, 2025.

Financial Performance

For the quarter ended June 30, 2025, Black Rose Industries reported standalone revenue from operations of ₹59.85 crore, with a net profit of ₹4.24 crore. The company's performance reflects its continued operations in the chemical industry.

Key Management Changes

The Board has made several important decisions regarding the company's management structure:

1. Chief Risk Officer Appointment: Mr. Ratan Agrawal, the current Chief Financial Officer, has been appointed as the Chief Risk Officer of the company.

2. Senior Management Designations: Dr. Pavankumar Aduri, Vice President-Innovation, and Mr. Bhavesh Shah, General Manager-Sales, have been designated as Senior Management Personnel. This move is part of the reorganization of the company's Key Managerial Personnel structure.

Dr. Aduri brings over 16 years of experience in the chemical industry, with a Ph.D. in Chemical Engineering. He has been instrumental in driving innovation across specialty chemicals, polymer additives, liquid formulations, and pigments.

Mr. Shah, with over 30 years of experience, holds a Master's in Management Studies (Finance) from NMIMS and has been associated with the company since 2008, leading critical functions in marketing and sales.

Corporate Governance

The company has taken steps to strengthen its corporate governance:

1. Secretarial Auditor Appointment: M/s. Shiv Hari Jalan & Co., Practicing Company Secretaries, have been appointed as Secretarial Auditors for a term of 5 years (FY 2025-26 to FY 2029-30), subject to shareholder approval.

2. Annual General Meeting: The 35th Annual General Meeting is scheduled for September 29, 2025, to be held via video conferencing.

Strategic Business Decision

In a significant move, the Board has approved, subject to shareholder approval, the closure, sale, or transfer of 100% shareholding in its wholly-owned material subsidiary, B.R. Chemicals Co. Limited, Japan. This subsidiary contributed ₹54.37 crore, representing 13.57% of the total consolidated income of the company in the last financial year.

The decision follows the earlier move to discontinue the subsidiary's business operations from January 30, 2025. This strategic step is expected to impact the company's consolidated financial structure, as the subsidiary also contributed 3.67% to the total consolidated net worth.

Black Rose Industries continues to adapt to market conditions and streamline its operations, focusing on its core chemical business in India. The company's actions reflect its commitment to enhancing operational efficiency and shareholder value in the evolving business landscape.